AND Guidelines Bundle

Diabetes Nutrition

AND GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/954048

Contents of this Issue

Navigation

Page 11 of 11

Disclaimer This Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations A1C, glycohemoglobin; BMI, body mass index; DKD, diabetic kidney disease; GFR, glomerular filtration rate; MNT, medical nutrition therapy; MNTT, multiple daily injections; RDN, registered dietitian nutritionist Source Academy of Nutrition and Dietetics. Evidence Analysis Library Diabetes Types 1 and 2 (2015) Evidence-Based Nutrition Practice Guideline, Chicago, IL. To view the entire Diabetes Type 1 and 2 2015 Guideline, including introduction, scope, harms/benefits and supporting evidence, visit www.andeal.org/dm 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2017 All rights reserved ANDDIA17122b Criteria for Recommendation Ratings Statement Definition Strong • Benefits clearly exceed the harms (or harms clearly exceed the benefits for a negative recommendation) • The quality of the supporting evidence is excellent/good (grade I or II) Fair • Benefits exceed the harms (or harms clearly exceed the benefits for a negative recommendation) • Quality of evidence is not as strong (grade II or III) Weak • Quality of evidence that exists is suspect • Or that well-done studies (grade I, II or III) show little clear advantage to one approach versus another Consensus • Expert opinion (grade IV) supports the guideline recommendation Insufficient Evidence • Both a lack of pertinent evidence (grade V) and/or an unclear balance between benefits and harms

Articles in this issue

Links on this page

Archives of this issue

view archives of AND Guidelines Bundle - Diabetes Nutrition